Reza Nazemzadeh
Experienced in Ganglioneuroma

Dr. Reza Nazemzadeh

Hematology | Oncology
Atrium Health
Atrium Health Levine Cancer Institute (GI/Gastrointestinal Cancer)
1021 Morehead Medical Drive, Building 1, Suite 5300, 
Charlotte, NC 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Experienced in Ganglioneuroma
Atrium Health
Atrium Health Levine Cancer Institute (GI/Gastrointestinal Cancer)
1021 Morehead Medical Drive, Building 1, Suite 5300, 
Charlotte, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Reza Nazemzadeh is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Nazemzadeh is rated as an Experienced provider by MediFind in the treatment of Ganglioneuroma. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, and Colorectal Cancer. Dr. Nazemzadeh is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
The University Of Texas
Residency
Vanderbilt University, Internal Medicine
Specialties
Hematology
Oncology
Licenses
Internal Medicine in NC
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine, Hematology
American Board Of Internal Medicine, Medical Oncology
Fellowships
Vanderbilt University, Hematology/Oncology
Hospital Affiliations
Carolinas Medical Center/behav Health
Languages Spoken
English
Farsi
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Atrium Health Levine Cancer Institute (GI/Gastrointestinal Cancer)
1021 Morehead Medical Drive, Building 1, Suite 5300, Charlotte, NC 28204
Call: 980-442-6410
Other Locations
Atrium Health Levine Cancer Institute
4525 Cameron Valley Parkway, Charlotte, NC 28211
Call: 980-442-0400

Additional Areas of Focus

Dr. Nazemzadeh has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Appendix Cancer
Esophageal Cancer
Lung Cancer
Prostate Cancer
Bladder Cancer
Pancreatic Cancer
Colorectal Cancer
Testicular Cancer
Anal Cancer
Liver Cancer
Stomach Cancer
View 1 Less Areas of Focus-

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer
Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer
Enrollment Status: Recruiting
Publish Date: November 14, 2025
Intervention Type: Drug, Device
Study Drugs: Gemcitabine, Nab-paclitaxel
Study Phase: Phase 3
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: May 09, 2025
Intervention Type: Device, Drug
Study Drug: Cisplatin-Gemcitabine
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trial

1 Total Publications

Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Journal: JCO precision oncology
Published: November 21, 2022
Similar Doctors
Distinguished in Ganglioneuroma
Dr. Michael B. Livingston
Oncology | Hematology Oncology
Distinguished in Ganglioneuroma
Dr. Michael B. Livingston
Oncology | Hematology Oncology
15830 Ballantyne Medical Pl, Ste 200, 
Charlotte, NC 
 (6.4 miles away)
980-442-9600
Languages Spoken:
English
See accepted insurances

Michael Livingston is an Oncologist and a Hematologist Oncology provider in Charlotte, North Carolina. Dr. Livingston is rated as a Distinguished provider by MediFind in the treatment of Ganglioneuroma. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Myxoid Liposarcoma.

Distinguished in Ganglioneuroma
Dr. Jeffrey S. Kneisl
Surgical Oncology | Oncology
Distinguished in Ganglioneuroma
Dr. Jeffrey S. Kneisl
Surgical Oncology | Oncology

Atrium Health Levine Cancer Institute (Rare & Complex Sarcoma)

1021 Morehead Medical Drive, Suite 3200, 
Charlotte, NC 
 (4.2 miles away)
980-442-3310
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Kneisl is a Surgical Oncologist and an Oncologist in Charlotte, North Carolina. Dr. Kneisl is rated as a Distinguished provider by MediFind in the treatment of Ganglioneuroma. His top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Rhabdomyosarcoma Embryonal, and Undifferentiated Pleomorphic Sarcoma. Dr. Kneisl is currently accepting new patients.

Johann H. Hsu
Advanced in Ganglioneuroma
Dr. Johann H. Hsu
Hematology | Oncology
Advanced in Ganglioneuroma
Dr. Johann H. Hsu
Hematology | Oncology

Atrium Health Levine Cancer Institute (Rare & Complex Sarcoma)

1021 Morehead Medical Drive, Suite 3200, 
Charlotte, NC 
 (4.2 miles away)
980-442-3310
Experience:
10+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Johann Hsu is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Hsu has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Ganglioneuroma. His top areas of expertise are Bone Tumor, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, and Synovial Sarcoma. Dr. Hsu is currently accepting new patients.

VIEW MORE GANGLIONEUROMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nazemzadeh's expertise for a condition
ConditionClose
    • Distinguished
    • Cholangiocarcinoma (Bile Duct Cancer)
      Dr. Nazemzadeh is
      Distinguished
      . Learn about Cholangiocarcinoma (Bile Duct Cancer).
      See more Cholangiocarcinoma (Bile Duct Cancer) experts
    • Colorectal Cancer
      Dr. Nazemzadeh is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Nazemzadeh is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Familial Pancreatic Cancer
      Dr. Nazemzadeh is
      Distinguished
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Lynch Syndrome
      Dr. Nazemzadeh is
      Distinguished
      . Learn about Lynch Syndrome.
      See more Lynch Syndrome experts
    • Neuroendocrine Tumor
      Dr. Nazemzadeh is
      Distinguished
      . Learn about Neuroendocrine Tumor.
      See more Neuroendocrine Tumor experts
    View All 8 Distinguished Conditions
    • Advanced
    • Ampullary Cancer
      Dr. Nazemzadeh is
      Advanced
      . Learn about Ampullary Cancer.
      See more Ampullary Cancer experts
    • Anal Cancer
      Dr. Nazemzadeh is
      Advanced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Appendix Cancer
      Dr. Nazemzadeh is
      Advanced
      . Learn about Appendix Cancer.
      See more Appendix Cancer experts
    • Bladder Cancer
      Dr. Nazemzadeh is
      Advanced
      . Learn about Bladder Cancer.
      See more Bladder Cancer experts
    • Carcinoid Syndrome
      Dr. Nazemzadeh is
      Advanced
      . Learn about Carcinoid Syndrome.
      See more Carcinoid Syndrome experts
    • Chronic Myelogenous Leukemia (CML)
      Dr. Nazemzadeh is
      Advanced
      . Learn about Chronic Myelogenous Leukemia (CML).
      See more Chronic Myelogenous Leukemia (CML) experts
    View All 19 Advanced Conditions
    • Experienced
    • Adult Immune Thrombocytopenia
      Dr. Nazemzadeh is
      Experienced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Adult Soft Tissue Sarcoma
      Dr. Nazemzadeh is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Adult T-Cell Leukemia
      Dr. Nazemzadeh is
      Experienced
      . Learn about Adult T-Cell Leukemia.
      See more Adult T-Cell Leukemia experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Nazemzadeh is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Alveolar Soft Part Sarcoma
      Dr. Nazemzadeh is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Anemia
      Dr. Nazemzadeh is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    View All 63 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.